Neuraltus

Developing proprietary small molecule immunomodulator drugs for neurodegenerative diseases

placePalo Alto, California, United States calendar_todayFounded 2009 groups5 employees language neuraltus.com

Registered entities

Investor mix

3 investors on record; lead investors include LVP, Adams Street Partners, VantagePoint Capital Partners.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon